I was at the House of Lords recently, and it got me thinking that what that second chamber does for parliament is similar in function to something I recommend to organizations running clinical trials. Which is to have someone oversee and scrutinize their patient recruitment and clinical operations activities to ensure best results.

Having a ‘second pair of eyes’ look over what you’re doing – and, in the case of clinical operations, also what your service providers and vendors are doing – can be very valuable for spotting errors or highlighting things that should work better if done differently.

In the same way that many members of the House of Lords have experience in relevant fields for the laws and parliamentary bills they work on, I recommend anyone involved in managing clinical trials should bring in experienced independent ‘outsiders’ to review and oversee their trial activities.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...